We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Par Pacific Holdings
PARR
$4.22B
| $225 | ﹤0.01% |
+4
| New | +$238 |
2026 Q2
0 quarters
|
|
3177
Krispy Kreme
DNUT
$534M
| $224 | ﹤0.01% |
+63
| New | +$225 |
2026 Q2
0 quarters
|
|
3178
Dauch Corp
DCH
$1.18B
| $223 | ﹤0.01% |
41
-2,259
| -98% | -$13.7K |
2025 Q1
5 quarters
|
|
3179
Clear Secure
YOU
$4.5B
| $223 | ﹤0.01% |
+4
| New | +$219 |
2026 Q2
0 quarters
|
|
3180
Central Garden & Pet Co
CENT
$2.63B
| $222 | ﹤0.01% |
+5
| New | +$196 |
2026 Q2
0 quarters
|
|
3181
Core Laboratories
CLB
$459M
| $222 | ﹤0.01% |
+19
| New | +$271 |
2026 Q2
0 quarters
|
|
3182
Syndax Pharmaceuticals
SNDX
$1.16B
| $219 | ﹤0.01% |
+10
| New | +$208 |
2026 Q2
0 quarters
|
|
3183
Alkami Technology
ALKT
$1.46B
| $218 | ﹤0.01% |
+12
| New | +$198 |
2026 Q2
0 quarters
|
|
3184
Nkarta
NKTX
$129M
| $216 | ﹤0.01% |
+76
| New | +$214 |
2026 Q2
0 quarters
|
|
3185
VTEX
VTEX
$686M
| $216 | ﹤0.01% |
+54
| New | +$206 |
2026 Q2
0 quarters
|
|
3186
GoodRx Holdings
GDRX
$1.15B
| $214 | ﹤0.01% |
+74
| New | +$188 |
2026 Q2
0 quarters
|
|
3187
Ardmore Shipping
ASC
$779M
| $212 | ﹤0.01% |
+15
| New | +$254 |
2026 Q2
0 quarters
|
|
3188
Village Super Market
VLGEA
$646M
| $212 | ﹤0.01% |
+5
| New | +$215 |
2026 Q2
0 quarters
|
|
3189
FVCBankcorp
FVCB
$316M
| $210 | ﹤0.01% |
+12
| New | +$191 |
2026 Q2
0 quarters
|
|
3190
Cytek Biosciences
CTKB
$682M
| $209 | ﹤0.01% |
+47
| New | +$201 |
2026 Q2
0 quarters
|
|
3191
TMC The Metals Company
TMC
$1.15B
| $209 | ﹤0.01% |
47
-1
| -2% | -$5 |
2025 Q2
4 quarters
|
|
3192
Banc of California
BANC
$2.72B
| $206 | ﹤0.01% |
+10
| New | +$191 |
2026 Q2
0 quarters
|
|
3193
Fox Factory Holding Corp
FOXF
$696M
| $204 | ﹤0.01% |
+12
| New | +$209 |
2026 Q2
0 quarters
|
|
3194
Outset Medical
OM
$74.8M
| $204 | ﹤0.01% |
+47
| New | +$206 |
2026 Q2
0 quarters
|
|
3195
Treace Medical Concepts
TMCI
$256M
| $204 | ﹤0.01% |
+51
| New | +$140 |
2026 Q2
0 quarters
|
|
3196
Beta Bionics
BBNX
$915M
| $204 | ﹤0.01% |
+13
| New | +$155 |
2026 Q2
0 quarters
|
|
3197
Arlo Technologies
ARLO
$1.3B
| $203 | ﹤0.01% |
+15
| New | +$203 |
2026 Q2
0 quarters
|
|
3198
SelectQuote
SLQT
$58.5M
| $203 | ﹤0.01% |
+240
| New | +$218 |
2026 Q2
0 quarters
|
|
3199
Global Industrial
GIC
$1.68B
| $201 | ﹤0.01% |
+6
| New | +$190 |
2026 Q2
0 quarters
|
|
3200
Invesco Ultra Short Duration ETF
GSY
$3.86B
| $201 | ﹤0.01% |
4
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.